Rink, Michael and Engel, Oliver and Gakis, Georgios and Fritsche, Hans Martin and Vetterlein, Malte W. and Soave, Armin and Peine, Sven and Aziz, Atiqullah and Dahlem, Roland and Stenzl, Arnulf and Burger, Maximilian and Shariat, Shahrokh F. and Fisch, Margit and Gild, Philipp (2017) The effect of ABO and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 35 (12): 671.e17. ISSN 1078-1439, 1873-2496
Full text not available from this repository. (Request a copy)Abstract
Objectives: To investigate the effect of AB0 and Rhesus factor expression blood group systems on outcomes of upper tract urothelial carcinoma patients treated with radical nephroureterectomy. Patients and methods: We analyzed data from 271 patients with upper tract urothelial carcinoma who underwent radical nephroureterectomy at 3 German academic institutions. Cox and logistic regression models assessed the association of AB0 blood group antigen and Rhesus factor expression with tumor biologic features and outcomes, respectively. Results: In total, 119 patients (43.9%) had blood group antigen A0, 42 patients (15.4%) antigen B0, 15 patients (5.5%) antigen AB, and 95 patients (35.0%) the antigen 00. A total of 231 patients (85.2%) were Rhesus factor positive. The AB0 blood group antigen expression was associated with a higher tumor grade (P = 0.049) and sessile tumor architecture (P = 0.019). Both, AB0 blood group system and Rhesus factor expression, were associated with worse performance status (P = 0.024, and P = 0.003, respectively). In contrast, Rhesus factor expression status was not associated with any clinicopathologic characteristics. Neither the AB0 blood group antigens nor the Rhesus factor was associated with survival. Conclusion: AB0 blood group antigens and Rhesus factor expression are not associated with survival. The association of the AB0 blood group antigens with adverse pathological features warrants further validation. (C) 2017 Elsevier Inc. All rights reserved.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | UPPER URINARY-TRACT; TRANSITIONAL-CELL CARCINOMA; BLADDER-CANCER; IMPACT; ASSOCIATION; RECURRENCE; CYSTECTOMY; MORTALITY; SURVIVAL; Prognosis; ABO blood group system; Rhesus blood group system; Transitional cell carcinoma; Upper tract urothelial carcinoma |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Urologie |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 14 Dec 2018 13:19 |
| Last Modified: | 19 Feb 2019 12:52 |
| URI: | https://pred.uni-regensburg.de/id/eprint/1799 |
Actions (login required)
 |
View Item |
